Product Information
ERY-TAB DR 333 MG TABLET is a generic product labeled by Arbor Pharmaceuticals, Inc., priced at $3.5039 per EA under NDC 24338012403. Its NADAC has been published 165 times since Feb 7, 2018.
Strength
333 mg/1
Manufacturer
Arbor Pharmaceuticals, Inc.NDC
24338012403
Classification
Generic
Dosage Form
TABLET, DELAYED RELEASE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ERYTHROMYCINApproval Type
Generic (ANDA)
FDA Application
ANDA062298On Market Since
4/18/2011
Pharmacological Classes
Price Statistics
The NADAC for ERY-TAB DR 333 MG TABLET has been published 165 times since Feb 7, 2018, and over the history we have for it it has declined 58.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $3.5039 per EA |
|---|---|
| All-time high | $8.5150 (Jan 16, 2019) |
| All-time low | $2.5179 (Aug 21, 2024) |
| 52-week high | $3.7275 |
| 52-week low | $3.3321 |
| Median price | $3.6848 |
| Average price | $4.9398 |
| Largest weekly change | -60.1% (Apr 17, 2024) |
| Weeks tracked | 165 |
| Tracking since | Feb 7, 2018 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ERY-TAB DR 333 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ERY-TAB DR 333 MG TABLET, manufactured by Arbor Pharmaceuticals, Inc., is $3.5039 per EA (NDC 24338012403), effective Jun 24, 2026.
How has the price of ERY-TAB DR 333 MG TABLET changed over time?
Over the history we have for it, the NADAC for ERY-TAB DR 333 MG TABLET has declined 58.9%. It has been tracked across 165 weekly CMS publications since Feb 7, 2018.
What are the highest and lowest recorded NADAC prices for ERY-TAB DR 333 MG TABLET?
Since Feb 7, 2018, the NADAC for ERY-TAB DR 333 MG TABLET has ranged from a low of $2.5179 (Aug 21, 2024) to a high of $8.5150 (Jan 16, 2019), with a median of $3.6848 per EA.
Are there cheaper alternatives to ERY-TAB DR 333 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as ERY-TAB DR 333 MG TABLET, but none are currently priced below it.
Who manufactures ERY-TAB DR 333 MG TABLET?
ERY-TAB DR 333 MG TABLET (NDC 24338012403) is labeled by Arbor Pharmaceuticals, Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification